10 research outputs found
Role of dual antiplatelet therapy in symptomatic patients with established vascular disease:putting the CHARISMA trial into therapeutic perspective
The CHARISMA (Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance) trial has spurred debate over subgroup analysis interpretation and prompted renewed consideration of the long-term role of dual aspirin and clopidogrel therapy (DAPT) in patients with established vascular disease